IMRT-Physics Aspects

S. Jack Wei, MD
University of Pennsylvania School of Medicine
Ultima Vez Modificado: 22 de octubre del 2003

Share article


English

Moderator: Theodore L. Phillips, MD., University of California, San Francisco

Lynn J. Verhey, PhD., University of California, San Francisco

  • IMRT is now commonly used for patient treatment.
  • Compared to 3D conformal treatment (3DCRT), IMRT requires increased commissioning time, increased treatment time, increased physics and dosimetry time, and patient-specific quality assurance (QA).
  • Due to the increased number of fields and small monitor units used per field, specific commissioning is required.
  • Specific commissioning and QA is needed for the multi-leaf collimators to verify leaf position, minimize leakage, etc.
  • The varying linear accelerators each have their own requirements (e.g. leaf design, interleaf field constraints, field size, etc.) depending on their manufacturer, and these each must be commissioned and verified.
  • Patient immobilization and target definition must be carefully performed.
  • Improved imaging during treatment is important for improving QA and the emerging technology of cone-beam CT has the potential to determine patient translation and rotation relative to a pre-treatment CT scan.
  • In conclusion, IMRT is increasingly becoming mature and requires vigilant and extensive QA
  • Improved imaging will allow better delivery of QA.

English
News
But white, nonwhite survivors engage in beneficial physical activity

Oct 5, 2010 - White female cancer survivors have more social support than nonwhites, according to research presented at the American Association for Cancer Research Conference on the Science of Cancer Health Disparities, held from Sept. 30 to Oct. 3 in Miami. The study also examined racial differences in participation in physical activity, a known beneficial factor in cancer survivorship outcomes.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información